Literature DB >> 10942113

Structure and polymorphism of the human gene for the interferon-induced p78 protein (MX1): evidence of association with alopecia areata in the Down syndrome region.

R Tazi-Ahnini1, F S di Giovine, A J McDonagh, A G Messenger, C Amadou, A Cox, G W Duff, M J Cork.   

Abstract

Alopecia areata (AA) is a chronic inflammatory disease characterised by patchy hair loss with T cell infiltration of hair follicles. AA occurs in approximately 0.1% of the general population, but this is increased to 9% in Down syndrome (DS). DS is associated with an additional copy (full or partial) of chromosome 21, and the DS region may potentially include genes involved in the pathogenesis of AA. MX1 is the gene encoding the interferon-induced p78 protein (MxA). MxA protein confers resistance to influenza viruses, and we have previously shown that MxA protein is strongly expressed in lesional anagen hair bulbs from patients with AA but not in normal follicles. We therefore studied the possible involvement of MX1 in the pathogenesis of AA. To establish markers in the MX1 region which could be screened by PCR-based methods, we defined the human MX1 exon/intron organisation and screened the exons and the introns by conformation-sensitive gel electrophoresis. We found that the MX1 gene contains 17 exons extending over 33 kb. The size and sequence of the region from exon 6 to exon 16 are highly conserved between human and mouse. Screening of 4747 bp within the MX1 gene revealed four single nucleotide polymorphisms in intron 6. These polymorphisms are concentrated within 147 bp and show strong linkage disequilibrium. In a case-control association study for the MX1 (+9959) polymorphism in 165 AA patients and 510 controls we found a significant association of this marker with AA (odds ratio 1.79, 95% CI 1.21-2.66, chi2 = 8.464, P = 0.0036). The risk of disease was greater for patchy AA (mild disease) and with early age at onset (odds ratio 2.34, 95% CI 1.24-4.43, P = 0.0072), providing new evidence of genetic heterogeneity in AA. Our demonstration of genetic association between the MX1 gene and disease supports the hypothesis that this is a new candidate gene in AA.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10942113     DOI: 10.1007/s004390000318

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Molecular cloning of the pufferfish (Takifugu rubripes) Mx gene and functional characterization of its promoter.

Authors:  Wai Ho Yap; Alice Tay; Sydney Brenner; Byrappa Venkatesh
Journal:  Immunogenetics       Date:  2003-01-09       Impact factor: 2.846

2.  Genomewide scan for linkage reveals evidence of several susceptibility loci for alopecia areata.

Authors:  Amalia Martinez-Mir; Abraham Zlotogorski; Derek Gordon; Lynn Petukhova; Jianhong Mo; T Conrad Gilliam; Douglas Londono; Chad Haynes; Jurg Ott; Maria Hordinsky; Krassimira Nanova; David Norris; Vera Price; Madeleine Duvic; Angela M Christiano
Journal:  Am J Hum Genet       Date:  2007-01-05       Impact factor: 11.025

3.  HLA antigens in individuals with down syndrome and alopecia areata.

Authors:  Juliany L Estefan; Juliana C Oliveira; Eliane D Abad; Simone B Saintive; Luis Cristóvão Ms Porto; Marcia Ribeiro
Journal:  World J Clin Cases       Date:  2014-10-16       Impact factor: 1.337

4.  Genomic structure, promoter analysis, and expression of the porcine (Sus scrofa) Mx1 gene.

Authors:  Anne V Thomas; Melanie Palm; Aurore D Broers; Hussein Zezafoun; Daniel J-M Desmecht
Journal:  Immunogenetics       Date:  2006-04-26       Impact factor: 2.846

5.  Role of nucleotide binding and GTPase domain dimerization in dynamin-like myxovirus resistance protein A for GTPase activation and antiviral activity.

Authors:  Alexej Dick; Laura Graf; Daniel Olal; Alexander von der Malsburg; Song Gao; Georg Kochs; Oliver Daumke
Journal:  J Biol Chem       Date:  2015-03-31       Impact factor: 5.157

6.  Notch4, a non-HLA gene in the MHC is strongly associated with the most severe form of alopecia areata.

Authors:  R Tazi-Ahnini; M J Cork; D Wengraf; A G Wilson; D J Gawkrodger; M P Birch; A G Messenger; A J G McDonagh
Journal:  Hum Genet       Date:  2003-02-14       Impact factor: 4.132

7.  Inhibition of tumor cell motility by the interferon-inducible GTPase MxA.

Authors:  J Frederic Mushinski; Phuongmai Nguyen; Lisa M Stevens; Chand Khanna; Sunmin Lee; Eun Joo Chung; Min-Jung Lee; Yeong Sang Kim; W Marston Linehan; Michel A Horisberger; Jane B Trepel
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

8.  Analysis and recognition of 5' UTR intron splice sites in human pre-mRNA.

Authors:  E Eden; S Brunak
Journal:  Nucleic Acids Res       Date:  2004-02-11       Impact factor: 16.971

9.  Influence of MX1 promoter rs2071430 G/T polymorphism on susceptibility to systemic lupus erythematosus.

Authors:  Suad AlFadhli; Mashael Al-Mutairi; Bader Al Tameemi; Rasheeba Nizam
Journal:  Clin Rheumatol       Date:  2016-01-27       Impact factor: 2.980

10.  Analysis of the monocyte chemoattractant protein 1 -2518 promoter polymorphism in Korean patients with alopecia areata.

Authors:  Seok-Beom Hong; Sheng-Yu Jin; Hae-Jeong Park; Joo-Ho Jung; Woo-Young Sim
Journal:  J Korean Med Sci       Date:  2006-02       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.